[1]
2011. Pharmacoeconomic aspects of poor adherence to treatment in multiple sclerosis management. Farmeconomia. Health economics and therapeutic pathways. 12, 3 (Sep. 2011), 107–117. DOI:https://doi.org/10.7175/fe.v12i3.127.